Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis
Open Access
- 1 September 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 24 (3) , 434-436
- https://doi.org/10.1128/aac.24.3.434
Abstract
The efficacies of ketoconazole and two new imidazole preparations, Bay N7133 and Bay L9139, were compared in a rat model of experimental candida vaginitis. With a dosage regimen of 10 mg/kg by gavage for 5 days, the cure rate for ketoconazole was 96% as compared with rates of 23 and 29% for Bay N7133 and Bay L9139, respectively (P less than 0.001). Follow-up vaginal cultures at 30 days revealed a relapse in only 1 of 27 rats treated with ketoconazole. Our subsequent experiment in which ketoconazole regimens of 10 mg/kg were compared with Bay N7133 and Bay L9139 regimens of 25 mg/kg demonstrated cure rates of 100, 15, and 82% for the respective agents.Keywords
This publication has 5 references indexed in Scilit:
- An Evaluation of Two Years of Clinical Experience with KetoconazoleClinical Infectious Diseases, 1980
- Ketoconazole in Experimental CandidosisClinical Infectious Diseases, 1980
- Ketoconazole in Vulvovaginal CandidosisClinical Infectious Diseases, 1980
- Evaluation of vaginal antifungal formulations in vivoPublished by Oxford University Press (OUP) ,1979
- Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycoticEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1979